PORTFOLIO

PORTFOLIO COMPANIES

ImmunoScape Pte. Ltd.

  • Co-Founder and CEO：
    Ng Choon Peng

URL:https://immunoscape.com/

COMPANY PROFILE

Enabling immunotherapy through high-dimensional immune profiling

ImmunoScape is a market-leading biotech company offering state-of-the-art immune profiling services and analytical tools. Their technology offers unprecedented immunological insights that underpin the development of immunotherapies for indications ranging from cancer to infectious and autoimmune diseases to the pharmaceutical industry.

COMPANY STORY

Origin

ImmunoScape was founded in December 2016 with the technology licensed from Dr Evan Newell’s laboratory at the Singapore Immunology Network in A*STAR.

Strength

ImmunoScape employs cutting-edge technologies and mass cytometry to measure alterations of immune cells and in particular, antigen specific T cells specificity for biomarker and target identification, offering valuable insights on efficacy & safety of immunotherapies in R&D and clinical phase.

UTEC’s value add

UTEC supports ImmunoScape in academic collaborations (especially with the University of Tokyo), business development and team-building strategy.

  • Immunological insights provided by ImmunoScape

  • Map of immune response landscape

BACK TO LIST BACK TO LIST
BACK TO LIST